DoctorLila Landowski
Senior Lecturer in Biomedical Sciences
Health Sciences
- Senior Lecturer in Biomedical SciencesHealth Sciences
- School of Health Sciences, Health Sciences, 440-01 MSP, Hobart CBD Campuses, TAS
RESEARCH SUMMARy
Expertise
Stroke
Nerve regeneration
Axon guidance
Peripheral Neuropathy
Chemotherapy-induced Neuropathy
Diabetic Neuropathy
Neurodevelopment
Stress and burnout
Technology overuse impacts on the brain
Histology (microanatomy)
Research Biography:
As a neuroscientist, Lila’s research expertise spans across axon guidance, therapeutic development for nerve injury, stroke and fatigue. In 2014, after completing her PhD at the Menzies Research Institute Tasmania, Lila trained at the Peripheral Nerve lab at the Mayo Clinic to cement her status as an emerging leader in the field of peripheral nerve injury. She was recruited to teach and coordinate neuroscience units at the Wicking Dementia Centre at the same time. In recent years, her research focus has shifted from peripheral neuropathy to stroke. She is currently a postdoctoral fellow in the lab of Professor David Howells. For several months across late 2016-early 2017, Lila spent time as a visiting scholar at the Florey Institute’s Melbourne Brain Centre (Austin Hospital, Melbourne), developing surgical skills research to bring back to UTAS. With the support of a $450,000 investment from the Royal Hobart Hospital Research Foundation, her foremost research goal is to transform the success of preclinical stroke research. Through improving preclinical models of stroke, we may save as much as $1.9bn in the $14.9bn research cost of developing new stroke therapies.
Research Themes
Lila’s research aligns to the theme of Better Health.
Her current research portfolio has two major projects (stroke and fatigue)
Stroke - The cost of stroke in the developed world is up to an estimated A$1475 billion a year. Despite decades of research, drug development for stroke has failed repeatedly. Of the 1000+ promising therapeutics developed for stroke in animal models, only one is used clinically. Even then, the utility and applicability of this drug is limited. Research from our laboratory suggests that the primary reason for the failure of translation arises from flaws with the stroke models themselves. However, we have devised a clever solution to overcome these limitations; my role is to establish this new gold-standard model of stroke. These improvements are critical: they will increase the face validity of stroke modelling, allow us to test hypotheses critical to our understanding of stroke biology and improve the success of preclinical translational stroke research. We estimate that even modest improvements in stroke modelling might achieve savings of ~$1.9bn in the estimated $14.6bn research cost of developing a new stroke therapy.
Fatigue - Fatigue is much more than just a sense of tiredness. It is also a debilitating symptom of many diseases and disorders, hampering peoples’ ability to perform the simplest of daily activities. The underlying mechanism of fatigue is unknown. We hypothesise that fatigue is ultimately a disorder resulting from an energy deficit in the brain.
Neonatal versus adult nerve regeneration – Neonate and young children's brains have a remarkable ability to recover from neuronal injury. Understanding this process will have very important implications for improving recovery from neurological diseases and injury in adults.
Neuropathy - Development of a therapeutic for chemotherapy induced neuropathy. Imagine surviving cancer, only to suffer from debilitating pain for the rest of your life? Unfortunately, this is a common reality for many people who have had chemotherapy for cancer. We have developed compelling evidence that the protein metallothionein can accelerate regeneration of peripheral nerves. Lila would like to identify whether metallothionein can be used as prophylactic agent to prevent or reduce chemotherapy-induced neuropathy.
FUNDED PROJECTS
- GRANTA new theory of fatigue: The role of AgRP neurons in ME/CFS1 Jan 2021 - 31 Dec 2024People funded by this grant:
- Sutherland B,
- Herzog H,
- Landowski L
- GRANTBlood-brain barrier energy dysfunction: the unifying cause of fatigue1 Jan 2017 - 30 Jun 2018People funded by this grant:
- Howells D,
- Sutherland B,
- Landowski L,
- Eaton E,
- Allan
- GRANTPaving the way for future stroke drug development: creating a new gold-standard model of stroke1 Jan 2017 - 31 Mar 2021People funded by this grant:
- Landowski L,
- Howells D,
- Castley H,
- Sutherland B,
- Kirkcaldie M
- GRANTDevelopment of a therapeutic agent for a chemotherapy-induced neuropathy1 Mar 2015 - 31 Jul 2016People funded by this grant:
- Taylor B,
- Landowski L,
- West A,
- Vickers J,
- Foa L